Medoc Pathway

PATHWAY

Medoc's PATHWAY Pain & Sensory Evaluation System introduces revolutionary new technology and capabilities in the area of objective evoked pain potential and
advanced stimulator products. These solutions have a modular design that can be tailored to specific needs and protocols, and offer an easy upgrade path.

This new, configurable platform expands on capabilities of theTSA-II NeuroSensory Analyzer, opening up exciting new
possibilities for pain and peripheral nerve disease research, as well as for implementation in pharmaceutical development and clinical applications.

In addition, the PATHWAY system offers exciting new possibilities in the area of small-fiber evoked potential (EP), with the
PATHWAY Model CHEPS; deep cold pain (to -10C) investigation with PATHWAY model ATS; and fMRI conditional options for both models.

Based on results conducted at a major US medical center with a leading pharmaceutical firm, PATHWAY model CHEPS has proven to evoke a definitive wave pattern corresponding with selective stimulation
of A-delta and C-fibers. Contact Heat Evoked Potential Simulation (CHEPS), unlike laser stimulators, is able to elicit a C-fiber response. CHEPS technology provides much greater versatility in
algorithm design and control, is easier and quicker to set up, and is a very cost-effective new option with superior benefits, as well as higher safety to patients and subjects.